Intelimed enables health systems to adopt clinical artificial intelligence in a safe, scalable, and governed way—without replacing existing technology. Through a vendor-neutral, standards-based platform built on HL7/FHIR/DICOM, we orchestrate FDA-cleared and CE-marked AI solutions for diagnostics, triage, and care-pathway optimization. We support a global shift from isolated pilots to strategic implementation, aligned with WHO SMART Guidelines, PH4H, data-governance best practices, and real-world performance monitoring. Intelimed integrates more than 80 SaMD into a single auditable environment, reducing operational friction and accelerating measurable clinical impact. What we do: • Clinical AI infrastructure (B2G/B2B) for national and institutional adoption. • Vendor-neutral orchestration on top of existing PACS/RIS/HIS. • Triage, diagnostic support, and clinical-pathway modules across primary and specialty care. • Data standardization and quality for analytics, research, and radiomics. • Governance and safety with privacy-by-design, auditability, and continuous model performance oversight. Our mission is to drive equitable access, better clinical outcomes, and higher system productivity, positioning AI as foundational infrastructure for Latin America’s healthcare future.
| Website | https://www.intelimed.ai/ |
| Employees | 7 (4 on RocketReach) |
| Founded | 2023 |
| Industry | Hospitals and Health Care |
Looking for a particular Intelimed.ai employee's phone or email?
Alan Nudman is the CEO and Co-founder of Intelimed.ai.
4 people are employed at Intelimed.ai.